The microenvironment in the development of MASLD-MASH-HCC and associated therapeutic in MASH-HCC

Global epidemiology of nonalcoholic fatty liver disease-Meta-analytic assessment of prevalence, incidence, and outcomes

Younossi, Z. M., Koenig, A. B., Abdelatif, D., Fazel, Y., Henry, L., & Wymer, M. (2016) · Hepatology · doi:10.1002/hep.28431 · Cited by 10,781 · see citing works

Atezolizumab plus bevacizumab in unresectable hepatocellular carcinoma

Finn, R. S., Qin, S., Ikeda, M., Galle, P. R., Ducreux, M., Kim, T.-Y., Kudo, M., Breder, V., Merle, P., Kaseb, A. O., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa1915745 · Cited by 7,470 · see citing works

The gut microbiota as an environmental factor that regulates fat storage

Bäckhed, F., Ding, H., Wang, T., Hooper, L. V., Koh, G. Y., Nagy, A., Semenkovich, C. F., & Gordon, J. I. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0407076101 · Cited by 6,245 · see citing works

<i>Faecalibacterium prausnitzii</i> is an anti-inflammatory commensal bacterium identified by gut microbiota analysis of Crohn disease patients

Sokol, H., Pigneur, B., Watterlot, L., Lakhdari, O., Bermúdez-Humarán, L. G., Gratadoux, J.-J., Blugeon, S., Bridonneau, C., Furet, J.-P., Corthier, G., et al. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0804812105 · Cited by 4,413 · see citing works

Hepatocellular carcinoma

Vogel, A., Meyer, T., Sapisochin, G., Salem, R., & Saborowski, A. (2022) · The Lancet · doi:10.1016/s0140-6736(22)01200-4 · Cited by 2,427 · see citing works

Obesity-induced gut microbial metabolite promotes liver cancer through senescence secretome

Yoshimoto, S., Loo, T. M., Atarashi, K., Kanda, H., Sato, S., Oyadomari, S., Iwakura, Y., Oshima, K., Morita, H., Hattori, M., et al. (2013) · Nature · doi:10.1038/nature12347 · Cited by 2,219 · see citing works

A phase 3, randomized, controlled trial of resmetirom in NASH with liver fibrosis

Harrison, S. A., Bedossa, P., Guy, C. D., Schattenberg, J. M., Loomba, R., Taub, R., Labriola, D., Moussa, S. E., Neff, G. W., Rinella, M. E., et al. (2024) · New England Journal of Medicine · doi:10.1056/nejmoa2309000 · Cited by 2,084 · see citing works

Mechanisms and disease consequences of nonalcoholic fatty liver disease

Loomba, R., Friedman, S. L., & Shulman, G. I. (2021) · Cell · doi:10.1016/j.cell.2021.04.015 · Cited by 2,002 · see citing works

Modeling NAFLD disease burden in China, France, Germany, Italy, Japan, Spain, United Kingdom, and United States for the period 2016–2030

Estes, C., Anstee, Q. M., Arias, M., Bantel, H., Bellentani, S., Caballería, J., Colombo, M., Craxı̀, A., Crespo, J., Day, C. P., et al. (2018) · Journal of Hepatology · doi:10.1016/j.jhep.2018.05.036 · Cited by 1,986 · see citing works

Global epidemiology of NAFLD-related HCC: trends, predictions, risk factors and prevention

Huang, D. Q., El-Serag, H. B., & Loomba, R. (2021) · Nature Reviews Gastroenterology &amp; Hepatology · doi:10.1038/s41575-020-00381-6 · Cited by 1,855 · see citing works

Resolving the fibrotic niche of human liver cirrhosis at single-cell level

Ramachandran, P., Dobie, R., Wilson-Kanamori, J. R., Dora, E. F., Henderson, B. E. P., Luu, N. T., Portman, J. R., Matchett, K. P., Brice, M., Marwick, J. A., et al. (2019) · Nature · doi:10.1038/s41586-019-1631-3 · Cited by 1,784 · see citing works

Characterization of gut microbiomes in nonalcoholic steatohepatitis (NASH) patients: A connection between endogenous alcohol and NASH

Zhu, L., Baker, S. S., Gill, C., Liu, W., Alkhouri, R., Baker, R. D., & Gill, S. R. (2013) · Hepatology · doi:10.1002/hep.26093 · Cited by 1,708 · see citing works

Role of Bile Acids and Bile Acid Receptors in Metabolic Regulation

Lefebvre, P., Cariou, B., Lien, F., Kuipers, F., & Staels, B. (2009) · Physiological Reviews · doi:10.1152/physrev.00010.2008 · Cited by 1,678 · see citing works

Gut microbiome–mediated bile acid metabolism regulates liver cancer via NKT cells

Ma, C., Han, M., Heinrich, B., Fu, Q., Zhang, Q., Sandhu, M., Agdashian, D., Terabe, M., Berzofsky, J. A., Fako, V., et al. (2018) · Science · doi:10.1126/science.aan5931 · Cited by 1,508 · see citing works

Increased intestinal permeability and tight junction alterations in nonalcoholic fatty liver disease

Miele, L., Valenza, V., La Torre, G., Montalto, M., Cammarota, G., Ricci, R., Mascianà, R., Forgione, A., Gabrieli, M. L., Perotti, G., et al. (2009) · Hepatology · doi:10.1002/hep.22848 · Cited by 1,434 · see citing works

Nonalcoholic Steatohepatitis

Sheka, A. C., Adeyi, O. A., Thompson, J., Hameed, B., Crawford, P. A., & Ikramuddin, S. (2020) · JAMA · doi:10.1001/jama.2020.2298 · Cited by 1,398 · see citing works

From NASH to HCC: current concepts and future challenges

Anstee, Q. M., Reeves, H. L., Kotsiliti, E., Govaere, O., & Heikenwalder, M. (2019) · Nature Reviews Gastroenterology &amp; Hepatology · doi:10.1038/s41575-019-0145-7 · Cited by 1,392 · see citing works

Lipid-associated macrophages control metabolic homeostasis in a Trem2-dependent manner

Jaitin, D. A., Adlung, L., Thaiss, C. A., Weiner, A., Li, B., Descamps, H., Lundgren, P., Bleriot, C., Liu, Z., Deczkowska, A., et al. (2019) · Cell · doi:10.1016/j.cell.2019.05.054 · Cited by 1,377 · see citing works

NASH limits anti-tumour surveillance in immunotherapy-treated HCC

Pfister, D., Núñez, N. G., Pinyol, R., Govaere, O., Pinter, M., Szydlowska, M., Gupta, R., Qiu, M., Deczkowska, A., Weiner, A., et al. (2021) · Nature · doi:10.1038/s41586-021-03362-0 · Cited by 1,294 · see citing works

Macrophage heterogeneity in liver injury and fibrosis

Tacke, F., & Zimmermann, H. W. (2014) · Journal of Hepatology · doi:10.1016/j.jhep.2013.12.025 · Cited by 1,061 · see citing works

Neutrophils mediate insulin resistance in mice fed a high-fat diet through secreted elastase

Talukdar, S., Oh, D. Y., Bandyopadhyay, G. K., Li, D., Xu, J., McNelis, J., Lu, M. M., Li, P., Yan, Q., Zhu, Y., et al. (2012) · Nature Medicine · doi:10.1038/nm.2885 · Cited by 966 · see citing works

Dietary cholesterol drives fatty liver-associated liver cancer by modulating gut microbiota and metabolites

Zhang, X., Coker, O. O., Chu, E. S., Fu, K., Lau, H. C. H., Wang, Y.-X., Chan, A. W. H., Wei, H., Yang, X., Sung, J. J. Y., et al. (2021) · Gut · doi:10.1136/gutjnl-2019-319664 · Cited by 841 · see citing works

The role of small intestinal bacterial overgrowth, intestinal permeability, endotoxaemia, and tumour necrosis factor α in the pathogenesis of non-alcoholic steatohepatitis

Wigg, A. J., Roberts-Thomson, I. C., Dymock, R. B., McCarthy, P. J., Grose, R. H., & Cummins, A. G. (2001) · Gut · doi:10.1136/gut.48.2.206 · Cited by 836 · see citing works

Hepatic inflammatory responses in liver fibrosis

Hammerich, L., & Tacke, F. (2023) · Nature Reviews Gastroenterology &amp; Hepatology · doi:10.1038/s41575-023-00807-x · Cited by 803 · see citing works

Resmetirom (MGL-3196) for the treatment of non-alcoholic steatohepatitis: a multicentre, randomised, double-blind, placebo-controlled, phase 2 trial

Harrison, S. A., Bashir, M. R., Guy, C. D., Zhou, R., Moylan, C. A., Frias, J. P., Alkhouri, N., Bansal, M. B., Baum, S., Neuschwander-Tetri, B. A., et al. (2019) · The Lancet · doi:10.1016/s0140-6736(19)32517-6 · Cited by 802 · see citing works

Landscape of Intercellular Crosstalk in Healthy and NASH Liver Revealed by Single-Cell Secretome Gene Analysis

Xiong, X., Kuang, H., Ansari, S., Liu, T., Gong, J., Wang, S., Zhao, X.-Y., Ji, Y., Li, C., Guo, L., et al. (2019) · Molecular Cell · doi:10.1016/j.molcel.2019.07.028 · Cited by 784 · see citing works

NAFLD causes selective CD4+ T lymphocyte loss and promotes hepatocarcinogenesis

Ma, C., Kesarwala, A. H., Eggert, T., Medina-Echeverz, J., Kleiner, D. E., Jin, P., Stroncek, D. F., Terabe, M., Kapoor, V., ElGindi, M., et al. (2016) · Nature · doi:10.1038/nature16969 · Cited by 766 · see citing works

Advancing the global public health agenda for NAFLD: a consensus statement

Lazarus, J. V., Mark, H. E., Anstee, Q. M., Arab, J. P., Batterham, R. L., Castera, L., Cortez-Pinto, H., Crespo, J., Cusi, K., Dirac, M. A., et al. (2022) · Nature Reviews Gastroenterology &amp; Hepatology · doi:10.1038/s41575-021-00523-4 · Cited by 757 · see citing works

Lipid accumulation and dendritic cell dysfunction in cancer

Herber, D. L., Cao, W., Nefedova, Y., Novitskiy, S. V., Nagaraj, S., Tyurin, V. A., Corzo, A., Cho, H.-I., Celis, E., Lenox, B. C., et al. (2010) · Nature Medicine · doi:10.1038/nm.2172 · Cited by 741 · see citing works

Interleukin-17 Signaling in Inflammatory, Kupffer Cells, and Hepatic Stellate Cells Exacerbates Liver Fibrosis in Mice

Meng, F., Wang, K., Aoyama, T., Grivennikov, S. I., Paik, Y., Scholten, D., Cong, M., Iwaisako, K., Liu, X., Zhang, M., et al. (2012) · Gastroenterology · doi:10.1053/j.gastro.2012.05.049 · Cited by 711 · see citing works

Protection from obesity and diabetes by blockade of TGF-β/smad3 signaling

Yadav, H., Quijano, C., Kamaraju, A. K., Gavrilova, O., Malek, R., Chen, W., Zerfas, P., Zhigang, D., Wright, E. C., Stuelten, C., et al. (2011) · Cell Metabolism · doi:10.1016/j.cmet.2011.04.013 · Cited by 709 · see citing works

Gut microbiota profiling of pediatric nonalcoholic fatty liver disease and obese patients unveiled by an integrated meta-omics-based approach

Del Chierico, F., Nobili, V., Vernocchi, P., Russo, A., De Stefanis, C., Gnani, D., Furlanello, C., Zandonà, A., Paci, P., Capuani, G., et al. (2017) · Hepatology · doi:10.1002/hep.28572 · Cited by 696 · see citing works

Metabolic Activation of Intrahepatic CD8+ T Cells and NKT Cells Causes Nonalcoholic Steatohepatitis and Liver Cancer via Cross-Talk with Hepatocytes

Wolf, M. J., Adili, A., Piotrowitz, K., Abdullah, Z., Boege, Y., Stemmer, K., Ringelhan, M., Simonavicius, N., Egger, M., Wohlleber, D., et al. (2014) · Cancer Cell · doi:10.1016/j.ccell.2014.09.003 · Cited by 678 · see citing works

Mechanisms of Fibrosis Development in Nonalcoholic Steatohepatitis

Schwabe, R. F., Tabas, I., & Pajvani, U. B. (2020) · Gastroenterology · doi:10.1053/j.gastro.2019.11.311 · Cited by 671 · see citing works

Hepatocellular Carcinoma Is Associated With Gut Microbiota Profile and Inflammation in Nonalcoholic Fatty Liver Disease

Ponziani, F. R., Bhoori, S., Castelli, C., Putignani, L., Rivoltini, L., CHIERICO, F. D., Sanguinetti, M., Morelli, D., Sterbini, F. P., Petito, V., et al. (2018) · Hepatology · doi:10.1002/hep.30036 · Cited by 670 · see citing works

Inflammation-induced IgA+ cells dismantle anti-liver cancer immunity

Shalapour, S., Lin, X.-J., Bastian, I. N., Brain, J., Burt, A. D., Aksenov, A. A., Vrbanac, A. F., Li, W., Perkins, A., Matsutani, T., et al. (2017) · Nature · doi:10.1038/nature24302 · Cited by 589 · see citing works

M2 Kupffer cells promote M1 Kupffer cell apoptosis: A protective mechanism against alcoholic and nonalcoholic fatty liver disease

Wan, J., Benkdane, M., Teixeira-Clerc, F., Bonnafous, S., Louvet, A., Lafdil, F., Pecker, F., Tran, A., Gual, P., Mallat, A., et al. (2014) · Hepatology · doi:10.1002/hep.26607 · Cited by 558 · see citing works

AMPK maintains cellular metabolic homeostasis through regulation of mitochondrial reactive oxygen species

Rabinovitch, R. C., Samborska, B., Faubert, B., Ma, E. H., Gravel, S.-P., Andrzejewski, S., Raissi, T. C., Pause, A., St.-Pierre, J., & Jones, R. G. (2017) · Cell Reports · doi:10.1016/j.celrep.2017.09.026 · Cited by 543 · see citing works

DAMPs and DAMP-sensing receptors in inflammation and diseases

Ma, M., Jiang, W., & Zhou, R. (2024) · Immunity · doi:10.1016/j.immuni.2024.03.002 · Cited by 541 · see citing works

Auto-aggressive CXCR6+ CD8 T cells cause liver immune pathology in NASH

Dudek, M., Pfister, D., Donakonda, S., Filpe, P., Schneider, A., Laschinger, M., Hartmann, D., Hüser, N., Meiser, P., Bayerl, F., et al. (2021) · Nature · doi:10.1038/s41586-021-03233-8 · Cited by 512 · see citing works

Neutrophil extracellular traps promote inflammation and development of hepatocellular carcinoma in nonalcoholic steatohepatitis

van der Windt, D. J., Sud, V., Zhang, H., Varley, P. R., Goswami, J., Yazdani, H. O., Tohme, S. T., Loughran, P., O'Doherty, R. M., Minervini, M. I., et al. (2018) · Hepatology · doi:10.1002/hep.29914 · Cited by 482 · see citing works

Gut microbiota impact on the peripheral immune response in non-alcoholic fatty liver disease related hepatocellular carcinoma

Behary, J., Amorim, N. M. L., Jiang, X., Raposo, A. E., Gong, L., McGovern, E., Ibrahim, R., Chu, F., Stephens, C., Jebeili, H., et al. (2021) · Nature Communications · doi:10.1038/s41467-020-20422-7 · Cited by 470 · see citing works

The portal inflammatory infiltrate and ductular reaction in human nonalcoholic fatty liver disease

Gadd, V. L., Skoien, R., Powell, E. E., Fagan, K. J., Winterford, C., Horsfall, L., Irvine, K., & Clouston, A. D. (2014) · Hepatology · doi:10.1002/hep.26937 · Cited by 452 · see citing works

Resmetirom for nonalcoholic fatty liver disease: a randomized, double-blind, placebo-controlled phase 3 trial

Harrison, S. A., Taub, R., Neff, G. W., Lucas, K. J., Labriola, D., Moussa, S. E., Alkhouri, N., & Bashir, M. R. (2023) · Nature Medicine · doi:10.1038/s41591-023-02603-1 · Cited by 435 · see citing works

Ductular reaction in liver diseases: pathological mechanisms and translational significances

Sato, K., Marzioni, M., Meng, F., Francis, H., Glaser, S., & Alpini, G. (2019) · Hepatology · doi:10.1002/hep.30150 · Cited by 423 · see citing works

TREM2-Transduced Myeloid Precursors Mediate Nervous Tissue Debris Clearance and Facilitate Recovery in an Animal Model of Multiple Sclerosis

Takahashi, K., Prinz, M., Stagi, M., Chechneva, O., & Neumann, H. (2007) · PLoS Medicine · doi:10.1371/journal.pmed.0040124 · Cited by 414 · see citing works

Gut Microbiome-Based Metagenomic Signature for Non-invasive Detection of Advanced Fibrosis in Human Nonalcoholic Fatty Liver Disease

Loomba, R., Seguritan, V., Li, W.-Z., Long, T., Klitgord, N., Bhatt, A., Dulai, P., Caussy, C., Bettencourt, R., Highlander, S., et al. (2019) · Cell Metabolism · doi:10.1016/j.cmet.2019.08.002 · Cited by 412 · see citing works

Obesity, Fat Mass and Immune System: Role for Leptin

Francisco, V., Pino, J., Campos-Cabaleiro, V., Ruiz-Fernández, C., Mera, A., Gonzalez-Gay, M. A., Gómez, R., & Gualillo, O. (2018) · Frontiers in Physiology · doi:10.3389/fphys.2018.00640 · Cited by 411 · see citing works

Metabolic Inflammation-Associated IL-17A Causes Non-alcoholic Steatohepatitis and Hepatocellular Carcinoma

Gomes, A. L., Teijeiro, A., Burén, S., Tummala, K. S., Yilmaz, M., Waisman, A., Theurillat, J.-P., Perna, C., & Djouder, N. (2016) · Cancer Cell · doi:10.1016/j.ccell.2016.05.020 · Cited by 401 · see citing works

Impaired Kupffer Cell Self-Renewal Alters the Liver Response to Lipid Overload during Non-alcoholic Steatohepatitis

Tran, S., Baba, I., Poupel, L., Dussaud, S., Moreau, M., Gélineau, A., Marcelin, G., Magréau-Davy, E., Ouhachi, M., Lesnik, P., et al. (2020) · Immunity · doi:10.1016/j.immuni.2020.06.003 · Cited by 400 · see citing works

Regulatory T-cell and neutrophil extracellular trap interaction contributes to carcinogenesis in non-alcoholic steatohepatitis

Wang, H., Zhang, H., Wang, Y., Brown, Z. J., Xia, Y., Huang, Z., Shen, C., Hu, Z., Beane, J., Ansa-Addo, E. A., et al. (2021) · Journal of Hepatology · doi:10.1016/j.jhep.2021.07.032 · Cited by 398 · see citing works

Dynamic shifts in the composition of resident and recruited macrophages influence tissue remodeling in NASH

Daemen, S., Gainullina, A., Kalugotla, G., He, L., Chan, M. M., Beals, J. W., Liss, K. H., Klein, S., Feldstein, A. E., Finck, B. N., et al. (2021) · Cell Reports · doi:10.1016/j.celrep.2020.108626 · Cited by 378 · cited 1× · see citing works

Cenicriviroc Treatment for Adults With Nonalcoholic Steatohepatitis and Fibrosis: Final Analysis of the Phase 2b CENTAUR Study

Ratziu, V., Sanyal, A., Harrison, S. A., Wong, V. W., Francque, S., Goodman, Z., Aithal, G. P., Kowdley, K. V., Seyedkazemi, S., Fischer, L., et al. (2020) · Hepatology · doi:10.1002/hep.31108 · Cited by 378 · see citing works

Resmetirom: First Approval

Keam, S. J. (2024) · Drugs · doi:10.1007/s40265-024-02045-0 · Cited by 378 · see citing works

Role of liver sinusoidal endothelial cells in non-alcoholic fatty liver disease

Hammoutene, A., & Rautou, P.-E. (2019) · Journal of Hepatology · doi:10.1016/j.jhep.2019.02.012 · Cited by 364 · see citing works

Nonalcoholic steatohepatitis-related hepatocellular carcinoma: pathogenesis and treatment

Llovet, J. M., Willoughby, C. E., Singal, A. G., Greten, T. F., Heikenwälder, M., El-Serag, H. B., Finn, R. S., & Friedman, S. L. (2023) · Nature Reviews Gastroenterology &amp; Hepatology · doi:10.1038/s41575-023-00754-7 · Cited by 354 · see citing works

Molecular Characterization of the Fecal Microbiota in Patients with Nonalcoholic Steatohepatitis – A Longitudinal Study

Wong, V. W., Tse, C., Lam, T. T., Wong, G. L., Chim, A. M., Chu, C. W., Yeung, D. K., Law, P. T. W., Kwan, H. S., Yu, J. Q., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0062885 · Cited by 342 · see citing works

IL-17A Plays a Critical Role in the Pathogenesis of Liver Fibrosis through Hepatic Stellate Cell Activation

Tan, Z., Qian, X., Jiang, R., Liu, Q., Wang, Y., Chen, C., Wang, X., Ryffel, B., & Sun, B. (2013) · The Journal of Immunology · doi:10.4049/jimmunol.1203013 · Cited by 330 · see citing works

Progression from Nonalcoholic Fatty Liver to Nonalcoholic Steatohepatitis Is Marked by a Higher Frequency of Th17 Cells in the Liver and an Increased Th17/Resting Regulatory T Cell Ratio in Peripheral Blood and in the Liver

Rau, M., Schilling, A.-K., Meertens, J., Hering, I., Weiss, J., Jurowich, C., Kudlich, T., Hermanns, H. M., Bantel, H., Beyersdorf, N., et al. (2016) · The Journal of Immunology · doi:10.4049/jimmunol.1501175 · Cited by 302 · see citing works

Dietary Factors Alter Hepatic Innate Immune System in Mice With Nonalcoholic Ratty Liver Disease * #

Li, Z., Soloski, M. J., & Diehl, A. M. (2005) · Hepatology · doi:10.1002/hep.20826 · Cited by 294 · see citing works

Tolerogenic maturation of liver sinusoidal endothelial cells promotes B7-homolog 1-dependent CD8+ T cell tolerance

Diehl, L., Schurich, A., Grochtmann, R., Hegenbarth, S., Chen, L., & Knolle, P. A. (2008) · Hepatology · doi:10.1002/hep.21965 · Cited by 291 · see citing works

Effect of modulation of PPAR-γ activity on Kupffer cells M1/M2 polarization in the development of non-alcoholic fatty liver disease

Luo, W., Xu, Q., Wang, Q., Wu, H., & Hua, J. (2017) · Scientific Reports · doi:10.1038/srep44612 · Cited by 285 · see citing works

Accumulation of natural killer T cells in progressive nonalcoholic fatty liver disease

Syn, W.-K., Oo, Y. H., Pereira, T. A., Karaca, G. F., Jung, Y., Omenetti, A., Witek, R. P., Choi, S. S., Guy, C. D., Fearing, C. M., et al. (2010) · Hepatology · doi:10.1002/hep.23599 · Cited by 283 · see citing works

Macrophages in obesity and non-alcoholic fatty liver disease: crosstalk with metabolism

Lefere, S., & Tacke, F. (2019) · JHEP Reports · doi:10.1016/j.jhepr.2019.02.004 · Cited by 278 · see citing works

Attenuated liver fibrosis in the absence of B cells

Novobrantseva, T. I. (2005) · Journal of Clinical Investigation · doi:10.1172/jci24798 · Cited by 277 · see citing works

Inhibiting Interleukin 11 Signaling Reduces Hepatocyte Death and Liver Fibrosis, Inflammation, and Steatosis in Mouse Models of Nonalcoholic Steatohepatitis

Widjaja, A. A., Singh, B. K., Adami, E., Viswanathan, S., Dong, J., D’Agostino, G. A., Ng, B., Lim, W., Tan, J., Paleja, B. S., et al. (2019) · Gastroenterology · doi:10.1053/j.gastro.2019.05.002 · Cited by 276 · see citing works

NKT-Associated Hedgehog and Osteopontin Drive Fibrogenesis in Non-Alcoholic Fatty Liver Disease

Syn, W.-K., Agboola, K. M., Swiderska, M., Michelotti, G. A., Liaskou, E., Pang, H., Xie, G., Philips, G., Chan, I. S., Karaca, G. F., et al. (2012) · Gut · doi:10.1136/gutjnl-2011-301857 · Cited by 266 · see citing works

Activated Monocytes in Peritumoral Stroma of Hepatocellular Carcinoma Promote Expansion of Memory T Helper 17 Cells

Kuang, D., Peng, C., Zhao, Q., Wu, Y., Chen, M.-S., & Zheng, L. (2009) · Hepatology · doi:10.1002/hep.23291 · Cited by 264 · see citing works

Prolonged hypernutrition impairs TREM2-dependent efferocytosis to license chronic liver inflammation and NASH development

Wang, X., He, Q., Zhou, C., Xu, Y., Liu, D., Fujiwara, N., Kubota, N., Click, A., Henderson, P., Vancil, J., et al. (2023) · Immunity · doi:10.1016/j.immuni.2022.11.013 · Cited by 262 · see citing works

Cytotoxic and regulatory roles of mucosal-associated invariant T cells in type 1 diabetes

Rouxel, O., silva, J. D., Beaudoin, L., Nel, I., Tard, C., Cagninacci, L., Kiaf, B., Oshima, M., Diedisheim, M., Salou, M., et al. (2017) · Nature Immunology · doi:10.1038/ni.3854 · Cited by 254 · see citing works

IL-17 Signaling Accelerates the Progression of Nonalcoholic Fatty Liver Disease in Mice

Harley, I. T. W., Stankiewicz, T. E., Giles, D. A., Softic, S., Flick, L. M., Cappelletti, M., Sheridan, R. M., Xanthakos, S. A., Steinbrecher, K. A., Sartor, R. B., et al. (2013) · Hepatology · doi:10.1002/hep.26746 · Cited by 252 · see citing works

Sinusoidal Endothelial Dysfunction Precedes Inflammation and Fibrosis in a Model of NAFLD

Pasarín, M., Mura, V. L., Gracia‐Sancho, J., García‐Calderó, H., Rodrı́guez-Vilarrupla, A., García‐Pagán, J. C., Bosch, J., & Abraldeṣ, J. G. (2012) · PLoS ONE · doi:10.1371/journal.pone.0032785 · Cited by 251 · see citing works

Hepatocyte Notch activation induces liver fibrosis in nonalcoholic steatohepatitis

Zhu, C., Kim, K., Wang, X., Bartolome, A., Salomao, M., Dongiovanni, P., Meroni, M., Graham, M. J., Yates, K. P., Diehl, A. M., et al. (2018) · Science Translational Medicine · doi:10.1126/scitranslmed.aat0344 · Cited by 250 · see citing works

Evidence-Based Management of Hepatocellular Carcinoma: Systematic Review and Meta-analysis of Randomized Controlled Trials (2002–2020)

Haber, P. K., Puigvehí, M., Castet, F., Lourdusamy, V., Montal, R., Tabrizian, P., Buckstein, M., Kim, E., Villanueva, A., Schwartz, M., et al. (2021) · Gastroenterology · doi:10.1053/j.gastro.2021.06.008 · Cited by 248 · see citing works

The Differential Roles of T Cells in Non-alcoholic Fatty Liver Disease and Obesity

Van Herck, M. A., Weyler, J., Kwanten, W. J., Dirinck, E. L., De Winter, B. Y., Francque, S. M., & Vonghia, L. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.00082 · Cited by 238 · see citing works

Mucosal-associated invariant T cells are a profibrogenic immune cell population in the liver

Hegde, P., Weiss, E., Paradis, V., Wan, J., Mabire, M., Sukriti, S., Rautou, P.-E., Albuquerque, M., Picq, O., Gupta, A. C., et al. (2018) · Nature Communications · doi:10.1038/s41467-018-04450-y · Cited by 232 · see citing works

Acetyl-CoA carboxylase inhibition disrupts metabolic reprogramming during hepatic stellate cell activation

Bates, J., Vijayakumar, A., Ghoshal, S., Marchand, B., Yi, S., Kornyeyev, D., Zagorska, A., Hollenback, D., Walker, K., Liu, K., et al. (2020) · Journal of Hepatology · doi:10.1016/j.jhep.2020.04.037 · Cited by 230 · see citing works

Soluble TREM2 levels reflect the recruitment and expansion of TREM2+ macrophages that localize to fibrotic areas and limit NASH

Hendrikx, T., Porsch, F., Kiss, M. G., Rajcic, D., Papac-Miličević, N., Hoebinger, C., Goederle, L., Hladik, A., Shaw, L. E., Horstmann, H., et al. (2022) · Journal of Hepatology · doi:10.1016/j.jhep.2022.06.004 · Cited by 220 · see citing works

CD8+ tissue-resident memory T cells promote liver fibrosis resolution by inducing apoptosis of hepatic stellate cells

Koda, Y., Teratani, T., Chu, P.-S., Hagihara, Y., Mikami, Y., Harada, Y., Tsujikawa, H., Miyamoto, K., Suzuki, T., Taniki, N., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-24734-0 · Cited by 219 · see citing works

CXCL10 plays a key role as an inflammatory mediator and a non-invasive biomarker of non-alcoholic steatohepatitis

Zhang, X., Shen, J., Man, K., Chu, E. S., Yau, T. O., Sung, J. C. Y., Go, M. Y. Y., Deng, J., Lu, L., Wong, V. W., et al. (2014) · Journal of Hepatology · doi:10.1016/j.jhep.2014.07.006 · Cited by 219 · see citing works

Vascular adhesion protein-1 promotes liver inflammation and drives hepatic fibrosis

Weston, C. J., Shepherd, E. L., Claridge, L. C., Rantakari, P., Curbishley, S. M., Tomlinson, J., Hübscher, S. G., Reynolds, G. M., Aalto, K., Anstee, Q. M., et al. (2014) · Journal of Clinical Investigation · doi:10.1172/jci73722 · Cited by 214 · see citing works

The Journal of Pathology

Wang, O., Lalani, E., Powell, S., Waxman, J., Abel, P. D., Jackson, D., & Stamp, G. (2006) · The Journal of Pathology · doi:10.1002/(issn)1096-9896 · Cited by 213 · see citing works

Microbiota‐Driven Activation of Intrahepatic B Cells Aggravates NASH Through Innate and Adaptive Signaling

Barrow, F., Khan, S., Fredrickson, G., Wang, H., Dietsche, K., Parthiban, P., Robert, S., Kaiser, T., Winer, S., Herman, A., et al. (2021) · Hepatology · doi:10.1002/hep.31755 · Cited by 210 · see citing works

The Role of Innate Immune Cells in Nonalcoholic Steatohepatitis

Cai, J., Zhang, X., & Li, H. (2019) · Hepatology · doi:10.1002/hep.30506 · Cited by 207 · see citing works

Combination of Mass Cytometry and Imaging Analysis Reveals Origin, Location, and Functional Repopulation of Liver Myeloid Cells in Mice

David, B. A., Rezende, R. M., Antunes, M. M., Santos, M. M., Lopes, M. A. F., Diniz, A. B., Pereira, R. V. S., Marchesi, S. C., Alvarenga, D. M., Nakagaki, B. N., et al. (2016) · Gastroenterology · doi:10.1053/j.gastro.2016.08.024 · Cited by 205 · see citing works

A high-fat diet and regulatory T cells influence susceptibility to endotoxin-induced liver injury

Ma, X., Hua, J., Mohamood, A. R., Hamad, A. R. A., Ravi, R. K., & Li, Z. (2007) · Hepatology · doi:10.1002/hep.21823 · Cited by 199 · see citing works

XCR1+ type 1 conventional dendritic cells drive liver pathology in non-alcoholic steatohepatitis

Deczkowska, A., David, E., Ramadori, P., Pfister, D., Safran, M., Li, B., Giladi, A., Jaitin, D. A., Barboy, O., Cohen, M., et al. (2021) · Nature Medicine · doi:10.1038/s41591-021-01344-3 · Cited by 197 · see citing works

The microbiota maintain homeostasis of liver-resident γδT-17 cells in a lipid antigen/CD1d-dependent manner

Li, F., Hao, X., Chen, Y., Bai, L., Gao, X., Lian, Z., Wei, H., Sun, R., & Tian, Z. (2017) · Nature Communications · doi:10.1038/ncomms13839 · Cited by 191 · see citing works

A defect in endothelial autophagy occurs in patients with non-alcoholic steatohepatitis and promotes inflammation and fibrosis

Hammoutene, A., Biquard, L., Lasselin, J., Kheloufi, M., Tanguy, M., Vion, A.-C., Mérian, J., Colnot, N., Loyer, X., Tedgui, A., et al. (2020) · Journal of Hepatology · doi:10.1016/j.jhep.2019.10.028 · Cited by 188 · see citing works

Dendritic Cells Limit Fibroinflammatory Injury in Nonalcoholic Steatohepatitis in Mice

Henning, J. R., Graffeo, C. S., Rehman, A., Fallon, N. C., Zambirinis, C. P., Ochi, A., Barilla, R., Jamal, M., Deutsch, M., Greco, S., et al. (2013) · Hepatology · doi:10.1002/hep.26267 · Cited by 185 · see citing works

Neutrophils in liver diseases: pathogenesis and therapeutic targets

Liu, K., Wang, F., & Xu, R. (2020) · Cellular and Molecular Immunology · doi:10.1038/s41423-020-00560-0 · Cited by 177 · see citing works

Dendritic Cell Populations With Different Concentrations of Lipid Regulate Tolerance and Immunity in Mouse and Human Liver

Ibrahim, J., Nguyen, A. H., Rehman, A. U., Ochi, A., Jamal, M., Graffeo, C. S., Henning, J. R., Zambirinis, C. P., Fallon, N. C., Barilla, R., et al. (2012) · Gastroenterology · doi:10.1053/j.gastro.2012.06.003 · Cited by 176 · see citing works

NKp46-Mediated Killing of Human and Mouse Hepatic Stellate Cells Attenuates Liver Fibrosis

Gur, C., Doron, S., Kfir-Erenfeld, S., Horwitz, E., Abu-tair, L., Safadi, R., & Mandelboim, O. (2012) · Gut · doi:10.1136/gutjnl-2011-301400 · Cited by 173 · see citing works

The balance between IL-17 and IL-22 produced by liver-infiltrating T-helper cells critically controls NASH development in mice

Rolla, S., Alchera, E., Imarisio, C., Bardina, V., Valente, G., Cappello, P., Mombello, C., Follenzi, A., Novelli, F., & Carini, R. (2016) · Clinical Science · doi:10.1042/cs20150405 · Cited by 158 · see citing works

PKM2-dependent metabolic skewing of hepatic Th17 cells regulates pathogenesis of non-alcoholic fatty liver disease

Moreno‐Fernandez, M. E., Giles, D. A., Oates, J. R., Chan, C. C., Damen, M. S. M. A., Doll, J., Stankiewicz, T. E., Chen, X., Chetal, K., Karns, R. A., et al. (2021) · Cell Metabolism · doi:10.1016/j.cmet.2021.04.018 · Cited by 158 · see citing works

Amelioration of high fat diet induced liver lipogenesis and hepatic steatosis by interleukin-22

Yang, L., Zhang, Y., Wang, L., Fan, F., Zhu, L., Li, Z., Ruan, X., Huang, H., Wang, Z., Huang, Z., et al. (2010) · Journal of Hepatology · doi:10.1016/j.jhep.2010.03.004 · Cited by 157 · see citing works

Kupffer Cell and Interleukin-12–Dependent Loss of Natural Killer T Cells in Hepatosteatosis

Kremer, M., Thomas, E., Milton, R. J., Perry, A. W., van Rooijen, N., Wheeler, M. D., Zacks, S., Fried, M., Rippe, R. A., & Hines, I. N. (2009) · Hepatology · doi:10.1002/hep.23292 · Cited by 156 · see citing works

Trends in body mass index, overweight and obesity among adults in the USA, the NHANES from 2003 to 2018: a repeat cross-sectional survey

Li, M., Gong, W., Wang, S., & Li, Z. (2022) · BMJ Open · doi:10.1136/bmjopen-2022-065425 · Cited by 148 · see citing works

Hepatic natural killer T‐cell and CD8+ T‐cell signatures in mice with nonalcoholic steatohepatitis

Bhattacharjee, J., Kirby, M., Softic, S., Miles, L., Salazar‐Gonzalez, R., Shivakumar, P., & Kohli, R. (2017) · Hepatology Communications · doi:10.1002/hep4.1041 · Cited by 146 · see citing works

The Hepatic Lymphatic Vascular System: Structure, Function, Markers, and Lymphangiogenesis

Tanaka, M., & Iwakiri, Y. (2016) · Cellular and Molecular Gastroenterology and Hepatology · doi:10.1016/j.jcmgh.2016.09.002 · Cited by 146 · see citing works

Role of immune responses in the development of NAFLD-associated liver cancer and prospects for therapeutic modulation

Yahoo, N., Dudek, M., Knolle, P. A., & Heikenwälder, M. F. (2023) · Journal of Hepatology · doi:10.1016/j.jhep.2023.02.033 · Cited by 145 · see citing works

Resmetirom: An Orally Administered, Small-molecule, Liver-directed, β-selective THR Agonist for the Treatment of Non-alcoholic Fatty Liver Disease and Non-alcoholic Steatohepatitis

Karim, G., & Bansal, M. B. (2023) · touchREVIEWS in Endocrinology · doi:10.17925/ee.2023.19.1.60 · Cited by 145 · see citing works

NKp46(+) natural killer cells attenuate metabolism-induced hepatic fibrosis by regulating macrophage activation in mice

Tosello‐Trampont, A., Krueger, P., Narayanan, S., Landes, S. G., Leitinger, N., & Hahn, Y. S. (2016) · Hepatology · doi:10.1002/hep.28389 · Cited by 142 · see citing works

Activation of thyroid hormone receptor‐β improved disease activity and metabolism independent of body weight in a mouse model of non‐alcoholic steatohepatitis and fibrosis

Kannt, A., Wohlfart, P., Madsen, A. N., Veidal, S. S., Feigh, M., & Schmoll, D. (2021) · British Journal of Pharmacology · doi:10.1111/bph.15427 · Cited by 140 · see citing works

B2-Lymphocyte Responses to Oxidative Stress-Derived Antigens Contribute to the Evolution of Nonalcoholic Fatty Liver Disease (NAFLD)

Bruzzì, S., Sutti, S., Giudici, G., Burlone, M. E., Ramavath, N. N., Toscani, A., Bozzola, C., Schneider, P., Morello, E., Parola, M., et al. (2018) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2018.06.015 · Cited by 139 · see citing works

Endothelial NO/cGMP/VASP Signaling Attenuates Kupffer Cell Activation and Hepatic Insulin Resistance Induced by High-Fat Feeding

Tateya, S., Rizzo, N. O., Handa, P., Cheng, A. M., Morgan-Stevenson, V., Daum, G., Clowes, A. W., Morton, G. J., Schwartz, M. W., & Kim, F. (2011) · Diabetes · doi:10.2337/db11-0255 · Cited by 138 · see citing works

Lactobacillus casei Shirota protects from fructose-induced liver steatosis: A mouse model

Wagnerberger, S., Spruss, A., Kanuri, G., Stahl, C., Schröder, M., Vetter, W., Bischoff, S. C., & Bergheim, I. (2012) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2012.01.014 · Cited by 123 · see citing works

Inhibition of Fatty Acid Translocase (FAT/CD36) Palmitoylation Enhances Hepatic Fatty Acid β-Oxidation by Increasing Its Localization to Mitochondria and Interaction with Long-Chain Acyl-CoA Synthetase 1

Zeng, S., Wu, F., Chen, M., Li, Y., You, M., Zhang, Y., Yang, P., Li, W., Ruan, X. Z., Zhao, L., et al. (2022) · Antioxidants and Redox Signaling · doi:10.1089/ars.2021.0157 · Cited by 118 · see citing works

A randomized, double-blind, multicenter, phase 2b study to evaluate the safety and efficacy of a combination of tropifexor and cenicriviroc in patients with nonalcoholic steatohepatitis and liver fibrosis: Study design of the TANDEM trial

Pedrosa, M. C., Seyedkazemi, S., Francque, S., Sanyal, A. J., Rinella, M. E., Charlton, M., Loomba, R. S., Ratziu, V., Kochuparampil, J. G., Fischer, L., et al. (2019) · Contemporary Clinical Trials · doi:10.1016/j.cct.2019.105889 · Cited by 117 · see citing works

Neutrophil-derived myeloperoxidase aggravates non-alcoholic steatohepatitis in low-density lipoprotein receptor-deficient mice

Rensen, S. S., Bieghs, V., Xanthoulea, S., Arfianti, E., Bakker, J. A., Shiri-Sverdlov, R., Hofker, M. H., Greve, J. W., & Buurman, W. A. (2012) · PLoS ONE · doi:10.1371/journal.pone.0052411 · Cited by 116 · see citing works

Major Histocompatibility Complex Class I–Related Chains A and B (Mic A/B): A Novel Role in Nonalcoholic Steatohepatitis

Kahraman, A., Schlattjan, M., Kocabayoglu, P., Yildiz-Meziletoglu, S., Schlensak, M., Fingas, C. D., Wedemeyer, I., Marquitan, G., Gieseler, R. K. H., Baba, H. A., et al. (2009) · Hepatology · doi:10.1002/hep.23253 · Cited by 116 · see citing works

Altered Phenotype and Functionality of Circulating Immune Cells Characterize Adult Patients With Nonalcoholic Steatohepatitis

Inzaugarat, M. E., Ferreyra Solari, N. E., Billordo, L. A., Abecasis, R., Gadano, A. C., & Cherñavsky, A. C. (2011) · Journal of Clinical Immunology · doi:10.1007/s10875-011-9571-1 · Cited by 115 · see citing works

Adoptive transfer of regulatory NKT lymphocytes ameliorates non‐alcoholic steatohepatitis and glucose intolerance in ob/ob mice and is associated with intrahepatic CD8 trapping

Elinav, E., Pappo, O., Sklair-Levy, M., Margalit, M., Shibolet, O., Gomori, M. J., Alper, R., Thalenfeld, B. E., Engelhardt, D., Rabbani, E., et al. (2006) · The Journal of Pathology · doi:10.1002/path.1950 · Cited by 114 · see citing works

CD8+ T cells regulate liver injury in obesity-related nonalcoholic fatty liver disease

Breuer, D., Pacheco, M. C., Washington, M. K., Montgomery, S. A., Hasty, A. H., & Kennedy, A. J. (2019) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00040.2019 · Cited by 112 · see citing works

Aberrant cholesterol metabolic signaling impairs antitumor immunosurveillance through natural killer T cell dysfunction in obese liver

Tang, W.-S., Zhou, J., Yang, W.-Q., Feng, Y., Wu, H., Mok, M., Zhang, L., Liang, Z., Liu, X., Xiong, Z.-W., et al. (2022) · Cellular & Molecular Immunology · doi:10.1038/s41423-022-00872-3 · Cited by 110 · see citing works

CD4+ T cell activation and inflammation in NASH-related fibrosis

Zhou, Y., Zhang, H., Yao, Y., Zhang, X., Guan, Y., & Zheng, F. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.967410 · Cited by 110 · see citing works

Mucosal-associated invariant T cells improve nonalcoholic fatty liver disease through regulating macrophage polarization

Li, Y., Huang, B., Jiang, X., Chen, W., Zhang, J., Wei, Y., Chen, Y., Lian, M., Bian, Z., Miao, Q., et al. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.01994 · Cited by 107 · see citing works

The biliary epithelium presents antigens to and activates natural killer T cells

Schrumpf, E., Tan, C., Karlsen, T. H., Sponheim, J., Björkström, N. K., Sundnes, O., Alfsnes, K., Kaser, A., Jefferson, D. M., Ueno, Y., et al. (2015) · Hepatology · doi:10.1002/hep.27840 · Cited by 104 · see citing works

Adipocyte Fatty Acid Binding Protein Promotes the Onset and Progression of Liver Fibrosis via Mediating the Crosstalk between Liver Sinusoidal Endothelial Cells and Hepatic Stellate Cells

Wu, X., Shu, L., Zhang, Z., Li, J., Zong, J., Cheong, L. Y., Ye, D., Lam, K. S. L., Song, E., Wang, C., et al. (2021) · Advanced Science · doi:10.1002/advs.202003721 · Cited by 104 · see citing works

The secretin/secretin receptor axis modulates liver fibrosis through changes in transforming growth factor‐β1 biliary secretion in mice

Wu, N., Meng, F., Invernizzi, P., Bernuzzi, F., Venter, J. K., Standeford, H. A., Onori, P., Marzioni, M., Alvaro, D., Franchitto, A., et al. (2016) · Hepatology · doi:10.1002/hep.28622 · Cited by 97 · see citing works

Transcriptional regulation of Hepatic Stellate Cell activation in NASH

Marcher, A.-B., Bendixen, S. M., Terkelsen, M. K., Hohmann, S. S., Hansen, M. H., Larsen, B. D., Mandrup, S., Dimke, H., Detlefsen, S., & Ravnskjaer, K. (2019) · Scientific Reports · doi:10.1038/s41598-019-39112-6 · Cited by 95 · see citing works

Murine CD103+ dendritic cells protect against steatosis progression towards steatohepatitis

Heier, E.-C., Meier, A., Julich-Haertel, H., Djudjaj, S., Rau, M., Tschernig, T., Geier, A., Boor, P., Lammert, F., & Lukacs-Kornek, V. (2017) · Journal of Hepatology · doi:10.1016/j.jhep.2017.01.008 · Cited by 94 · see citing works

Emerging concepts in biliary repair and fibrosis

Fabris, L., Spirlı̀, C., Cadamuro, M., Fiorotto, R., & Strazzabosco, M. (2017) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00452.2016 · Cited by 93 · see citing works

Differential Activation of Hepatic Invariant NKT Cell Subsets Plays a Key Role in Progression of Nonalcoholic Steatohepatitis

Maricic, I., Marrero, I., Eguchi, A., Nakamura, R., Johnson, C. D., Dasgupta, S., Hernandez, C. D., Nguyen, P. S., Swafford, A. D., Knight, R., et al. (2018) · The Journal of Immunology · doi:10.4049/jimmunol.1800614 · Cited by 92 · see citing works

Formation of Fenestrae in Murine Liver Sinusoids Depends on Plasmalemma Vesicle-Associated Protein and Is Required for Lipoprotein Passage

Herrnberger, L., Hennig, R., Kremer, W., Hellerbrand, C., Göpferich, A. M., Kalbitzer, H. R., & Tamm, E. R. (2014) · PLoS ONE · doi:10.1371/journal.pone.0115005 · Cited by 92 · see citing works

Novel Role of IL-13 in Fibrosis Induced by Nonalcoholic Steatohepatitis and Its Amelioration by IL-13R-Directed Cytotoxin in a Rat Model

Shimamura, T., Fujisawa, T., Husain, S. R., Kioi, M., Nakajima, A., & Puri, R. K. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.181.7.4656 · Cited by 91 · see citing works

Implication of the Hedgehog pathway in hepatocellular carcinoma

Corte, C. M. D., Viscardi, G., Papaccio, F., Esposito, G., Martini, G., Ciardiello, D., Martinelli, E., Ciardiello, F., & Morgillo, F. (2017) · World Journal of Gastroenterology · doi:10.3748/wjg.v23.i24.4330 · Cited by 90 · see citing works

Interferon regulatory factor 1(IRF-1) activates anti-tumor immunity via CXCL10/CXCR3 axis in hepatocellular carcinoma (HCC)

Yan, Y., Zheng, L., Du, Q., Yazdani, H. O., Dong, K., Guo, Y., & Geller, D. A. (2021) · Cancer Letters · doi:10.1016/j.canlet.2021.03.002 · Cited by 89 · see citing works

γδ T Cells Promote Steatohepatitis by Orchestrating Innate and Adaptive Immune Programming

Torres‐Hernandez, A., Wang, W., Nikiforov, Y., Tejada, K., Torres, L., Kalabin, A., Adam, S., Wu, J., Lu, L., Chen, R., et al. (2020) · Hepatology · doi:10.1002/hep.30952 · Cited by 80 · see citing works

CX3CR1-expressing inflammatory dendritic cells contribute to the progression of steatohepatitis

Sutti, S., Locatelli, I., Bruzzì, S., Jindal, A., Vacchiano, M., Bozzola, C., & Albano, E. (2015) · Clinical Science · doi:10.1042/cs20150053 · Cited by 80 · see citing works

Tim-3/Galectin-9 Regulate the Homeostasis of Hepatic NKT Cells in a Murine Model of Nonalcoholic Fatty Liver Disease

Tang, Z.-H., Liang, S., Potter, J. J., Jiang, X., Mao, H., & Li, Z. (2013) · The Journal of Immunology · doi:10.4049/jimmunol.1202814 · Cited by 80 · see citing works

Activated Natural Killer Cell Promotes Nonalcoholic Steatohepatitis Through Mediating JAK/STAT Pathway

Wang, F., Zhang, X., Liu, W.-X., Zhou, Y.-F., Wei, W.-C., Liu, D.-B., Wong, C., Sung, J. J. Y., & Yu, J. (2021) · Cellular and Molecular Gastroenterology and Hepatology · doi:10.1016/j.jcmgh.2021.08.019 · Cited by 78 · see citing works

The Role of Innate Cells Is Coupled to a Th1-Polarized Immune Response in Pediatric Nonalcoholic Steatohepatitis

Solari, N. E. F., Inzaugarat, M. E., Baz, P., Matteo, E. D., Lezama, C., Galoppo, M., Galoppo, C., & Cherñavsky, A. C. (2012) · Journal of Clinical Immunology · doi:10.1007/s10875-011-9635-2 · Cited by 78 · see citing works

Increased proteinase 3 and neutrophil elastase plasma concentrations are associated with non-alcoholic fatty liver disease (NAFLD) and type 2 diabetes

Mirea, A.-M., Toonen, E. J. M., van den Munckhof, I., Munsterman, I. D., Tjwa, E. T. T. L., Jaeger, M., Oosting, M., Schraa, K., Rutten, J. H. W., van der Graaf, M., et al. (2019) · Molecular Medicine · doi:10.1186/s10020-019-0084-3 · Cited by 77 · see citing works

Oral Administration of OKT3 MAb to Patients with NASH, Promotes Regulatory T-cell Induction, and Alleviates Insulin Resistance: Results of a Phase IIa Blinded Placebo-Controlled Trial

Lalazar, G., Mizrahi, M., Turgeman, I., Adar, T., Yaʼacov, A. B., Shabat, Y., Assy, N., Hemed, N., Zolotarovya, L., Lichtenstein, Y., et al. (2015) · Journal of Clinical Immunology · doi:10.1007/s10875-015-0160-6 · Cited by 77 · see citing works

oxLDL induces injury and defenestration of human liver sinusoidal endothelial cells via LOX1

Zhang, Q., Liu, J., Liu, J., Huang, W., Tian, L., Quan, J., Wang, Y., & Niu, R. (2014) · Journal of Molecular Endocrinology · doi:10.1530/jme-14-0049 · Cited by 77 · see citing works

Interleukin-15-mediated inflammation promotes non-alcoholic fatty liver disease

Donates, Y. C., Lacraz, G., Ghobadi, F., Rakotoarivelo, V., Orkhis, S., Mayhue, M., Chen, Y.-G., Rola‐Pleszczynski, M., Menéndez, A., Ilangumaran, S., et al. (2016) · Cytokine · doi:10.1016/j.cyto.2016.01.020 · Cited by 75 · see citing works

Characterization of the immune cell landscape of patients with NAFLD

Diedrich, T., Kummer, S., Galante, A., Drolz, A., Schlicker, V., Lohse, A., Kluwe, J., Eberhard, J., & Wiesch, J. S. Z. (2020) · PLoS ONE · doi:10.1371/journal.pone.0230307 · Cited by 74 · see citing works

Retained NK cell phenotype and functionality in non-alcoholic fatty liver disease

Stiglund, N., Strand, K., Cornillet, M., Stål, P., Thorell, A., Zimmer, C. L., Näslund, E., Karlgren, S., Nilsson, H., Mellgren, G., et al. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.01255 · Cited by 72 · see citing works

High Dimensional Single-Cell Analysis Reveals iNKT Cell Developmental Trajectories and Effector Fate Decision

Baranek, T., Lebrigand, K., Herbozo, C. D. A., Gonzalez, L., Bogard, G., Dietrich, C., Magnone, V., Boisseau, C., Jouan, Y., Trottein, F., et al. (2020) · Cell Reports · doi:10.1016/j.celrep.2020.108116 · Cited by 72 · see citing works

Dual role of B7 costimulation in obesity-related nonalcoholic steatohepatitis and metabolic dysregulation

Chatzigeorgiou, A., Chung, K., García-Martín, R., Alexaki, V. I., Ameln, A. K., Phieler, J., Sprott, D., Kanczkowski, W., Tzanavari, T., Bdeir, M., et al. (2014) · Hepatology · doi:10.1002/hep.27233 · Cited by 71 · see citing works

Is there an ‘ideal’ diet for patients with NAFLD?

Pugliese, N., Torres, M. C. P., Petta, S., Valenti, L. V. C., Giannini, E. G., & Aghemo, A. (2021) · European Journal of Clinical Investigation · doi:10.1111/eci.13659 · Cited by 68 · see citing works

NF-κB1 deficiency stimulates the progression of non-alcoholic steatohepatitis (NASH) in mice by promoting NKT-cell-mediated responses

Locatelli, I., Sutti, S., Vacchiano, M., Bozzola, C., & Albano, E. (2012) · Clinical Science · doi:10.1042/cs20120289 · Cited by 68 · see citing works

β-Glycosphingolipids improve glucose intolerance and hepatic steatosis of the Cohen diabetic rat

Zigmond, E., Zangen, S. W., Pappo, O., Sklair‐Levy, M., Lalazar, G., Zolotaryova, L., Raz, I., & Ilan, Y. (2008) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.90634.2008 · Cited by 68 · see citing works

Dietary macronutrients and the aging liver sinusoidal endothelial cell

Cogger, V. C., Mohamad, M., Solon‐Biet, S. M., Senior, A. M., Warren, A., O'Reilly, J. N., Tùng, B. T., Svistounov, D., McMahon, A. C., Fraser, R., et al. (2016) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00949.2015 · Cited by 67 · see citing works

T cells: Friends and foes in NASH pathogenesis and hepatocarcinogenesis

Ramadori, P., Kam, S., & Heikenwalder, M. (2022) · Hepatology · doi:10.1002/hep.32336 · Cited by 64 · see citing works

Targeting Liver Fibrosis with a Cell-penetrating Protease-activated Receptor-2 (PAR2) Pepducin

Shearer, A. M., Rana, R., Austin, K. M., Baleja, J., Nguyen, N., Bohm, A., Covic, L., & Kuliopulos, A. (2016) · Journal of Biological Chemistry · doi:10.1074/jbc.m116.732743 · Cited by 64 · see citing works

Liver endothelial cells in NAFLD and transition to NASH and HCC

Velliou, R.-I., Legaki, A., Nikolakopoulou, P., Vlachogiannis, N. I., & Chatzigeorgiou, A. (2023) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-023-04966-7 · Cited by 63 · see citing works

The Detrimental Role of Regulatory T Cells in Nonalcoholic Steatohepatitis

Dywicki, J., Buitrago‐Molina, L. E., Noyan, F., Davalos‐Misslitz, A. C., Hupa‐Breier, K. L., Lieber, M., Hapke, M., Schlue, J., Falk, C. S., Raha, S., et al. (2022) · Hepatology Communications · doi:10.1002/hep4.1807 · Cited by 57 · see citing works

Role of Intrahepatic B Cells in Non-Alcoholic Fatty Liver Disease by Secreting Pro-Inflammatory Cytokines and Regulating Intrahepatic T Cells

Zhang, F., Jiang, W. W., Li, X., Qiu, X. Y., Wu, Z., Chi, Y. J., Cong, X., & Liu, Y. L. (2016) · Journal of Digestive Diseases · doi:10.1111/1751-2980.12362 · Cited by 57 · see citing works

Macrophage metabolism, phenotype, function, and therapy in hepatocellular carcinoma (HCC)

Huang, J., Wu, Q., Geller, D. A., & Yan, Y. (2023) · Journal of Translational Medicine · doi:10.1186/s12967-023-04716-0 · Cited by 57 · see citing works

Free fatty acids differentially downregulate chemokines in liver sinusoidal endothelial cells: insights into non-alcoholic fatty liver disease

McMahan, R. H., Porsche, C. E., Edwards, M. G., & Rosen, H. R. (2016) · PLOS ONE · doi:10.1371/journal.pone.0159217 · Cited by 55 · see citing works

Toll-Like Receptor-7 Signaling Promotes Nonalcoholic Steatohepatitis by Inhibiting Regulatory T Cells in Mice

Roh, Y. S., Kim, J. W., Park, S., Shon, C., Kim, S., Eo, S. K., Kwon, J. K., Lim, C. W., & Kim, B. (2018) · The American Journal of Pathology · doi:10.1016/j.ajpath.2018.07.011 · Cited by 55 · see citing works

Gamma Delta T-lymphocytes in Hepatitis C and Chronic Liver Disease

Rajoriya, N., Fergusson, J. R., Leithead, J., & Klenerman, P. (2014) · Frontiers in Immunology · doi:10.3389/fimmu.2014.00400 · Cited by 55 · see citing works

Resmetirom: The First Food and Drug Administration–Approved Medication for Nonalcoholic Steatohepatitis (NASH)

Guirguis, E. H., Dougherty, J., Thornby, K., Grace, Y., & Mack, K. (2024) · Annals of Pharmacotherapy · doi:10.1177/10600280241259528 · Cited by 52 · see citing works

Knockout of neutrophil elastase protects against western diet induced nonalcoholic steatohepatitis in mice by regulating hepatic ceramides metabolism

Chen, J., Liang, B., Bian, D., Luo, Y., Yang, J., Li, Z., Zhuang, Z., Zang, S., & Shi, J. (2019) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2019.08.111 · Cited by 50 · see citing works

Cell-Specific Transport and Thyroid Hormone Receptor Isoform Selectivity Account for Hepatocyte-Targeted Thyromimetic Action of MGL-3196

Hönes, G. S., Sivakumar, R. G., Hoppe, C., König, J., Führer, D., & Moeller, L. C. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232213714 · Cited by 50 · see citing works

Hepatic NK cells attenuate fibrosis progression of non‐alcoholic steatohepatitis in dependent of CXCL10‐mediated recruitment

Fan, Y., Zhang, W., Wei, H.-M., Sun, R., Tian, Z., & Chen, Y.-Y. (2019) · Liver international (Print) · doi:10.1111/liv.14307 · Cited by 49 · see citing works

OX40 Regulates Both Innate and Adaptive Immunity and Promotes Nonalcoholic Steatohepatitis.

Sun, G.-Y., Jin, H., Zhang, C.-P., Meng, H., Zhao, X.-Y., Wei, D., Ou, X.-J., Wang, Q.-Y., Li, S.-X., Wang, T., et al. (2018) · Cell Reports · doi:10.1016/j.celrep.2018.12.006 · Cited by 48 · see citing works

Group 3 innate lymphoid cells protect steatohepatitis from high-fat diet induced toxicity

Hamaguchi, M., Okamura, T., Fukuda, T., Nishida, K., Yoshimura, Y., Hashimoto, Y., Ushigome, E., Nakanishi, N., Majima, S., Asano, M., et al. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.648754 · Cited by 47 · see citing works

Roles of Hepatic Innate and Innate-Like Lymphocytes in Nonalcoholic Steatohepatitis

Chen, Y., & Tian, Z. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.01500 · Cited by 47 · see citing works

Immunotherapy with oral administration of humanized anti-CD3 monoclonal antibody: a novel gut-immune system-based therapy for metaflammation and NASH

Ilan, Y., Shailubhai, K., & Sanyal, A. J. (2018) · Clinical & Experimental Immunology · doi:10.1111/cei.13159 · Cited by 45 · see citing works

Nonalcoholic steatohepatitis in hepatocarcinoma: new insights about its prognostic role in patients treated with lenvatinib

Rimini, M., Kudo, M., Tada, T., Shigeo, S., Kang, W., Suda, G., Jefremow, A., Burgio, V., Iavarone, M., Tortora, R., et al. (2021) · ESMO Open · doi:10.1016/j.esmoop.2021.100330 · Cited by 44 · see citing works

Absence of invariant natural killer T cells deteriorates liver inflammation and fibrosis in mice fed high-fat diet

Miyagi, T., Takehara, T., Uemura, A., Nishio, K., Shimizu, S., Kodama, T., Hikita, H., Li, W., Sasakawa, A., Tatsumi, T., et al. (2010) · Journal of Gastroenterology · doi:10.1007/s00535-010-0272-y · Cited by 43 · see citing works

Mesenteric lymph node CD4+ T lymphocytes migrate to liver and contribute to non-alcoholic fatty liver disease

Su, L. C., Wu, Z., Chi, Y., Song, Y., Xu, J., Tan, J., Xu, C., & Liu, Y. (2019) · Cellular Immunology · doi:10.1016/j.cellimm.2019.01.005 · Cited by 43 · see citing works

Diet Reversal and Immune Modulation Show Key Role for Liver and Adipose Tissue T Cells in Murine Nonalcoholic Steatohepatitis

Herck, M. A. V., Vonghia, L., Kwanten, W. J., Julé, Y., Vanwolleghem, T., Ebo, D. G., Michielsen, P. P., Man, J. G. D., Gama, L., Winter, B. Y. D., et al. (2020) · Cellular and Molecular Gastroenterology and Hepatology · doi:10.1016/j.jcmgh.2020.04.010 · Cited by 43 · see citing works

Early Cost-Effectiveness and Price Threshold Analyses of Resmetirom: An Investigational Treatment for Management of Nonalcoholic Steatohepatitis

Javanbakht, M., Fishman, J., Moloney, E., Rydqvist, P., & Ansaripour, A. (2022) · PharmacoEconomics - Open · doi:10.1007/s41669-022-00370-2 · Cited by 43 · see citing works

Targeting EFHD2 inhibits interferon-γ signaling and ameliorates non-alcoholic steatohepatitis

Fu, J., Liu, J., Wu, W., Chen, Y., Lu, G., Cao, Q., Meng, H., Tong, J., Zhu, J., Wang, X.-J., et al. (2024) · Journal of Hepatology · doi:10.1016/j.jhep.2024.04.009 · Cited by 43 · see citing works

Targeting NFATc4 attenuates non-alcoholic steatohepatitis in mice

Du, M., Wang, X., Yuan, L., Liu, B., Mao, X., Huang, D., Yang, L., Huang, K., Zhang, F., Wang, Y., et al. (2020) · Journal of Hepatology · doi:10.1016/j.jhep.2020.07.030 · Cited by 41 · see citing works

The immunoregulatory effects of CD8 T‐cell–derived perforin on diet‐induced nonalcoholic steatohepatitis

Wang, T., Sun, G.-Y., Wang, Y., Li, S.-X., Zhao, X.-Y., Zhang, C.-P., Jin, H., Tian, D., Liu, K., Shi, W., et al. (2019) · The FASEB Journal · doi:10.1096/fj.201802534rr · Cited by 40 · see citing works

Secretome of senescent hepatic stellate cells favors malignant transformation from nonalcoholic steatohepatitis-fibrotic progression to hepatocellular carcinoma

Zhou, Y., Zhang, L., Ma, Y., Xie, L. H., Yang, Y.-Y., Cheng, J., Chen, H., Zhou, Y., Song, G., Ding, J., et al. (2023) · Theranostics · doi:10.7150/thno.85369 · Cited by 35 · see citing works

Depletion of B cell‐activating factor attenuates hepatic fat accumulation in a murine model of nonalcoholic fatty liver disease

Nakamura, Y., Abe, M., Kawasaki, K., Miyake, T., Watanabe, T., Yoshida, O., Hirooka, M., Matsuura, B., & Hiasa, Y. (2019) · Scientific Reports · doi:10.1038/s41598-018-37403-y · Cited by 34 · see citing works

Inhibition of Secretin/Secretin Receptor Axis Ameliorates NAFLD Phenotypes

Chen, L., Wu, N., Kennedy, L. L., Francis, H., Ceci, L., Zhou, T., Samala, N. R., Kyritsi, K., Wu, C., Sybenga, A. B., et al. (2021) · Hepatology · doi:10.1002/hep.31871 · Cited by 33 · see citing works

Outcomes after curative therapy for hepatocellular carcinoma in patients with non-alcoholic fatty liver disease: a meta-analysis and review of current literature

Chin, K. M., Prieto, M., Cheong, C. K., Martino, M. D., Ielpo, B., Goh, B. K. P., & Koh, Y. X. (2021) · HPB · doi:10.1016/j.hpb.2021.01.009 · Cited by 32 · see citing works

The effect of feeding and fasting on fenestrations in the liver sinusoidal endothelial cell

O'Reilly, J. N., Cogger, V. C., Fraser, R., & Couteur, D. G. L. (2010) · Pathology · doi:10.3109/00313021003636469 · Cited by 30 · see citing works

Transarterial Chemoembolization of Hepatocellular Carcinoma: Propensity Score Matching Study Comparing Survival and Complications in Patients with Nonalcoholic Steatohepatitis Versus Other Causes Cirrhosis

Young, S. J., Sanghvi, T. S., Rubin, N., Hall, D., Roller, L., Charaf, Y., & Golzarian, J. (2019) · CardioVascular and Interventional Radiology · doi:10.1007/s00270-019-02363-x · Cited by 24 · see citing works

Prognosis after hepatic resection of patients with hepatocellular carcinoma related to non-alcoholic fatty liver disease: meta-analysis

Su, J., Deng, Z., Teng, Y., Koh, Y. X., Zhang, W., Zheng, M., Xie, S., Huo, R., Chen, C.-J., Ma, L., et al. (2023) · BJS Open · doi:10.1093/bjsopen/zrac167 · Cited by 23 · see citing works

MyD88 in myofibroblasts enhances nonalcoholic fatty liver disease-related hepatocarcinogenesis via promoting macrophage M2 polarization

Liu, Y., Chen, H., Yan, X., Zhang, J., Deng, Z., Huang, M., Gu, J., & Zhang, J. (2024) · Cell Communication and Signaling · doi:10.1186/s12964-024-01489-x · Cited by 23 · see citing works

Percutaneous radiofrequency ablation for hepatocellular carcinoma developed on non‐alcoholic fatty liver disease

Nguyen, N. T., Rode, A., Trillaud, H., Aubé, C., Manichon, A., Hocquelet, A., Paisant, A., Dao, T., Nahon, P., Ganne‐Carrié, N., et al. (2021) · Liver International · doi:10.1111/liv.15129 · Cited by 21 · see citing works

BCATc inhibitor 2 ameliorated mitochondrial dysfunction and apoptosis in oleic acid-induced non-alcoholic fatty liver disease model

Lü, Z., Sun, G., Pan, X.-A., Qu, X.-H., Yang, P., Chen, Z., Han, X., & Wang, T. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.1025551 · Cited by 20 · see citing works

Endothelial group IVA phospholipase A2 promotes hepatic fibrosis with sinusoidal capillarization in the early stage of non-alcoholic steatohepatitis in mice

Kawashita, E., Ozaki, T., Ishihara, K., Kashiwada, C., & Akiba, S. (2022) · Life Sciences · doi:10.1016/j.lfs.2022.120355 · Cited by 18 · see citing works

Non-Parenchymal Cells and the Extracellular Matrix in Hepatocellular Carcinoma in Non-Alcoholic Fatty Liver Disease

van Son, K. C., Verschuren, L., Hanemaaijer, R., Reeves, H. L., Takkenberg, R. B., Drenth, J. P. H., Tushuizen, M. E., & Holleboom, A. G. (2023) · Cancers · doi:10.3390/cancers15041308 · Cited by 15 · see citing works

Myeloid TLR4 signaling promotes post-injury withdrawal resolution of murine liver fibrosis

Takimoto, Y., Chu, P., Nakamoto, N., Hagihara, Y., Mikami, Y., Miyamoto, K., Morikawa, R., Teratani, T., Taniki, N., Fujimori, S., et al. (2023) · iScience · doi:10.1016/j.isci.2023.106220 · Cited by 15 · see citing works

First‐line sorafenib sequential therapy and liver disease etiology for unresectable hepatocellular carcinoma using inverse probability weighting: A multicenter retrospective study

Shimose, S., Hiraoka, A., Nakano, M., Iwamoto, H., Tanaka, M., Tanaka, T., Noguchi, K., Aino, H., Ogata, K., Kajiwara, M., et al. (2021) · Cancer Medicine · doi:10.1002/cam4.4367 · Cited by 15 · see citing works

Galectin-12 modulates Kupffer cell polarization to alter the progression of nonalcoholic fatty liver disease

Lee, J., Wang, Y.-C., Hsu, Y.-A., Chen, C.-S., Weng, R.-C., Lu, Y.-P., Chuang, C., & Wan, L. (2023) · Glycobiology · doi:10.1093/glycob/cwad062 · Cited by 14 · see citing works

Inhibition of Checkpoint Kinase 1 (CHK1) Upregulates Interferon Regulatory Factor 1 (IRF1) to Promote Apoptosis and Activate Anti-Tumor Immunity via MICA in Hepatocellular Carcinoma (HCC)

Li, X., Huang, J., Wu, Q., Du, Q., Wang, Y., Huang, Y., Cai, X., Geller, D. A., & Yan, Y. (2023) · Cancers · doi:10.3390/cancers15030850 · Cited by 13 · see citing works

Author Correction: Transcriptional network analysis implicates altered hepatic immune function in NASH development and resolution

Haas, J. T., Vonghia, L., Mogilenko, D. A., Verrijken, A., Molendi‐Coste, O., Fleury, S., Deprince, A., Nikitin, A., Woitrain, E., Ducrocq-Geoffroy, L., et al. (2019) · Nature Metabolism · doi:10.1038/s42255-019-0093-0 · Cited by 7 · see citing works

Sterile inflammation in MASH: emerging role of extracellular RNA and therapeutic strategies

Raza, S., Mahamood, R., Medhe, P., Shahi, A., Yadav, A., Tewari, A., & Sinha, R. A. (2025) · npj Metabolic Health and Disease · doi:10.1038/s44324-025-00083-0 · Cited by 21 · see citing works

Liver Stiffness Rises Early in MASLD and Drives Inflammation, Lipid Dysmetabolism, and Fibrosis via Piezo1–YAP Mechanotransduction

Ma, J., Xie, N., Wang, Z., Liang, X., Han, Y., Zhao, Q., Wang, M., Lu, H., Kou, W., Alazawi, W., et al. (2026) · Advanced Science · doi:10.1002/advs.202519109 · Cited by 14 · see citing works

Gut Microbiota Changes in Metabolic Dysfunction-Associated Steatohepatitis and Inflammatory Bowel Disease: Common Pathogenic Features

Scarlata, G. G. M., Morano, D., Ismaiel, A., Spagnuolo, R., Luzza, F., Dumitrascu, D. L., & Abenavoli, L. (2025) · Current Issues in Molecular Biology · doi:10.3390/cimb47100847 · Cited by 12 · see citing works

Constructing biomimetic microenvironments for liver regeneration

(2025) · doi:10.1186/s12951-025-03729-9 · Cited by 11 · see citing works

Lipid Metabolism Reprogramming in Tumor-Associated Macrophages Modulates Their Function in Primary Liver Cancers

Oliviero, B., Caretti, A., Mondelli, M. U., & Mantovani, S. (2025) · Cancers · doi:10.3390/cancers17111858 · Cited by 11 · see citing works

Liver Sinusoidal Endothelial Cells and Their Regulation of Immunology, Collagenization, and Bioreactivity in Fatty Liver: A Narrative Review

Abdulmajeed, R. J., & Sergi, C. M. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26168006 · Cited by 11 · see citing works

MPTP mediated Ox-mtDNA release inducing macrophage pyroptosis and exacerbating MCD-induced MASH via promoting the ITPR3/Ca2+/NLRP3 pathway

Zhang, Q., Chen, L., Liu, J.-Y., Liu, T., Wang, R., Wu, X., & Li, S. (2025) · Journal of Translational Medicine · doi:10.1186/s12967-025-07302-8 · Cited by 10 · see citing works

Macrophage and inflammation in diabetes and metabolic dysfunction-associated steatotic liver disease: From mechanisms to therapeutic strategies

Zhang, C., Liu, S., & Yang, M. J. (2025) · World Journal of Diabetes · doi:10.4239/wjd.v16.i9.110515 · Cited by 9 · see citing works

The Interplay Between Cellular Senescence and Lipid Metabolism in the Progression of Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)

Mastoridou, E. M., GOUSSIA, A. C., Kataki, A., Koniaris, E., Glantzounis, G. K., Papoudou‐Bai, A., Kanavaros, P., & Charchanti, A. V. (2026) · International Journal of Molecular Sciences · doi:10.3390/ijms27021066 · Cited by 9 · see citing works

TET3 is a common epigenetic immunomodulator of pathogenic macrophages

Liu, B., Dai, Y., Wang, Z., Song, J., Du, Y., Lv, H., Bellone, S., Yang, Y.-H., Kennedy, A. J., Zhang, S., et al. (2025) · Journal of Clinical Investigation · doi:10.1172/jci194879 · Cited by 8 · see citing works

Beyond the liver: targeting the hepatic microenvironment and multi-organ networks for innovative MASH therapy

Fu, R., Zhang, F., Fu, J., Li, Y., Zhu, X., Ding, Q., & Zhu, Y. Z. (2025) · Metabolism and Target Organ Damage · doi:10.20517/mtod.2025.163 · Cited by 6 · see citing works

Decoding the heterogeneity of liver-resident macrophages in chronic liver diseases: therapeutic responses to immunomodulatory strategies

Ouyang, R., Li, X., Hao, J., Lin, J., Lan, H. Y., Peng, J., Li, X., Tian, Z., & Sun, Y. (2025) · Frontiers in Pharmacology · doi:10.3389/fphar.2025.1708240 · Cited by 5 · see citing works

Role of gut microbiota in the development of metabolic dysfunction-associated steatotic liver disease in inflammatory bowel disease

Sokal-Dembowska, A., Ergan, K., & Jarmakiewicz-Czaja, S. (2025) · World Journal of Gastroenterology · doi:10.3748/wjg.v31.i40.111375 · Cited by 4 · see citing works

Targeting Inflammation and Immune Regulation in Chronic Inflammation Associated Cancers

Rabiu, L., Chinn, M., Chen, F., Yerkinkazhina, Y., Tian, Y., & Zhu, W. (2026) · Cancer Science · doi:10.1111/cas.70360 · Cited by 4 · see citing works

Loss of immunometabolic adaptability in MASH: gut-derived signals drive macrophage reprogramming and fibrosis

Li, Y. C., Hu, Y., He, Y. M., Yang, Y., Xue, D., Xue, E., Jia, J., Zhang, W., & Wang, J. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2026.1793092 · Cited by 4 · see citing works

The Mitochondrial–Autophagy Axis in MASLD : Mechanisms, Crosstalk, and Therapeutic Targets

Bhaduri, G., Kalia, A., Saboo, B., & Bandyopadhyay, S. (2026) · Comprehensive physiology · doi:10.1002/cph4.70155 · Cited by 3 · see citing works

Immune crosstalk in metabolic dysfunction-associated steatotic liver disease: interactions between innate and adaptive immunity

Li, X., Jin, K., Fang, J., Ma, X., He, J., Lu, A., Jia, Z., & Shi, A. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2026.1835197 · Cited by 3 · see citing works

Calcium imbalance drives organelle network collapse and immune remodeling: novel pathogenic mechanisms in MASLD progression

Xu, S., Jiang, Z., Zhang, Q., & Guo, J. Z. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2026.1879836 · Cited by 2 · see citing works

Burden of Eosinophilic Esophagitis and Gastroesophageal Reflux Disease in Metabolic Dysfunction–Associated Steatotic Liver Disease: A Comprehensive US Healthcare Analysis

Chowdhary, R., Prasad, S., Koo, T. H., Liu, B. D. X., Sunkesula, V., Lindsey, A. S., & Fass, R. (2026) · Journal of Gastroenterology and Hepatology · doi:10.1111/jgh.70609 · Cited by 2 · see citing works

A Robust Marine Collagen Peptide–Agarose 3D Culture System for In Vitro Modeling of Hepatocellular Carcinoma and Anti-Cancer Therapeutic Development

Rajbongshi, L., Kim, J., Lee, J.-E., Lee, S.-R., Hwang, S.-Y., Kim, Y., Hong, Y. M., Oh, S., Kim, B. S., Lee, D., et al. (2025) · Marine Drugs · doi:10.3390/md23100386 · Cited by 1 · see citing works

Targeting STE20-type kinase MST3 improves metabolic dysfunction-associated steatohepatitis without affecting hepatocellular carcinoma development in mice

Zhang, J., Gongye, X., Kovooru, L., Andersson, E., Asiedu, B., Amrutkar, M., Gul, N., Myers, C., Booten, S. L., Lind, D. E., et al. (2026) · BMC Medicine · doi:10.1186/s12916-026-04812-0 · Cited by 1 · see citing works

Wendan decoction modulates Parasutterella to influence fatty acid metabolism in MAFLD via the FXR/PPARα/CYP4A12A axis

Zhang, Y., Wang, J., Zhu, W., Zhang, Y., Ma, T., Fang, H., Du, J., Chen, Z., Li, W., Zhang, X., et al. (2026) · Chinese Medicine · doi:10.1186/s13020-026-01474-1 · Cited by 1 · see citing works

Radiogenomics and machine learning in hepatocellular carcinoma: from foundations to clinical translation

Ye, Y., Zhu, W., Liu, J., Ye, L., Shang, Y., Xu, H., & An, P. (2026) · World Journal of Surgical Oncology · doi:10.1186/s12957-026-04280-z · Cited by 1 · see citing works

Alcohol consumption exacerbates high-fat diet-mediated disruptions in myelopoiesis and osteoclastogenesis in mouse models of metabolic dysfunction-associated liver diseases

Hemati, H., Blanton, M. B., Rutt, L. N., Keiran, N., Geron, R. D., Lima, F., McCullough, R. L., & Messaoudi, I. (2026) · Frontiers in Endocrinology · doi:10.3389/fendo.2026.1783132 · Cited by 1 · see citing works

Hepatocarcinogenesis in Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD): Emerging Roles of Interleukin-10 and Transcriptomic Insights into IL-10 Signaling Rewiring

Solleiro-Villavicencio, H., Méndez-García, L. A., Baltazar-Pérez, I., Pineda-Pérez, P. F., & Alfaro, A. (2026) · Biomedicines · doi:10.3390/biomedicines14051093 · Cited by 1 · see citing works

The immunometabolic mechanisms and therapeutic targets of metabolic dysfunction-associated steatohepatitis

Yu, J., & Peng, Y. (2026) · Frontiers in Medicine · doi:10.3389/fmed.2026.1801906 · Cited by 1 · see citing works

When the Liver Flares: Inflammatory and Immunometabolic Mechanisms Driving the Transition from MASLD to MASH

Vecchio, C., Sheferaw, A. N., Kivumbi, E., Stoppa, I., Pantham, D., Christaki, F., Provera, A., Dianzani, U., & Sutti, S. (2026) · Inflammation · doi:10.1007/s10753-026-02545-z · Cited by 1 · see citing works

Research Progress on Mesenchymal Stem Cells-Derived Small Size Vesicles for the Treatment of Liver Diseases

Meng, C., Liu, M., Qi, Q., Cao, L., Lei, Q., Liu, X., & Wang, M. (2026) · International Journal of Nanomedicine · doi:10.2147/ijn.s601322

Is metabolic dysfunction-associated steatotic liver disease truly irrelevant? Unmasking the heterogeneity and confounders in pancreatic cancer outcomes

Xiong, Z.-K., Jiang, Y.-Z., Lin, Y.-H., Cao, J.-D., Deng, T.-Y., & Zheng, Y. (2026) · World Journal of Gastroenterology · doi:10.3748/wjg.119356

Metabolic Rewiring in MASLD: From Disease Mechanisms to Precision Medicine

Lonardo, A., & Weiskirchen, R. (2026) · Metabolites · doi:10.3390/metabo16080529

Mechanism-Oriented Model Selection in MASH Research: Insights from the iHFC Diet and TSOD/TSNO Mice

Ichimura‐Shimizu, M., Shao, W., Ogawa, H., Tachibana, S., & Tsuneyama, K. (2026) · Livers · doi:10.3390/livers6050089

MASLD beyond the liver: decoding the gut–genetic–metabolic nexus

Attieh, P., Nassif, M., Maghzal, M., Bedran, A., Kassas, J., Othman, M., Sahyoun, F., Harb, F., Azar, S. T., & Ghadieh, H. E. (2026) · Frontiers in Gastroenterology · doi:10.3389/fgstr.2026.1824548

Metabolic and Bariatric Surgery as a Therapeutic Option for MASLD: Outcome, Mechanism, and Long-Term Implications

Reichert, M., Strowitzki, M. J., Tuffs, C., Amati, A., Amin, D., Raj, S., Sprenger, T., Hecker, A., & Schneider, M. (2026) · Zeitschrift für Gastroenterologie · doi:10.1055/a-2927-4771

A metabolite-centered view of hepatic stellate cells in MASLD-related liver cancer

Weiskirchen, R. (2026) · Cancer Plus · doi:10.36922/cp026350057

Association of Multiparametric Magnetic Resonance Imaging-Derived Lipid Content in the Liver and Tumorous Liver Tissue with Hepatic Metastatic Characteristics in Uveal Melanoma

Fückel, S., Dix, C., Hepp, T., Mathy, C. S., Tkotz, K., Uder, M., Berking, C., Erdmann, M., & Bäuerle, T. (2026) · Livers · doi:10.3390/livers6050100

Beyond fibrosis: the molecular roadmap from MASLD to hepatocellular carcinoma

Nevi, L., Altomare, A., Gallo, P., Taffon, C., Musarra, T., Baiocchini, A., & Carotti, S. (2026) · Frontiers in Oncology · doi:10.3389/fonc.2026.1933386

Correlation of Structured Lifestyle Modification Versus Standard Care with Progression Markers from Non-Alcoholic Fatty Liver Disease to Decompensated Chronic Liver Disease In Adults Aged 30-60 Years

Panezai, R. A., Malik, A., Panezai, S. A., Kareem, K., & Khan, M. (2026) · Pakistan journal of advances in medicine and medical research · doi:10.69837/pjammr.v4i2.143

Metabolic Dysfunction-Associated Steatotic Liver Disease and Cardiovascular Disease: An Integrated Narrative Review from Molecular Mechanisms to Nutritional and Bioactive Strategies

Castelli, S., Aiello, G., Muthanna, F. M. S., Lammi, C., Tripodi, G., Aiello, V., Lombardo, M., & Baldelli, S. (2026) · Metabolites · doi:10.3390/metabo16110855

When lipids silence immunity: Dendritic cell death in MASLD-associated HCC

Kocheise, L., & Schneider, K. M. (2026) · Journal of Hepatology · doi:10.1016/j.jhep.2026.06.008

Immunotherapy resistance in MASLD-related hepatocellular carcinoma: special immune microenvironment and gut microbiota

Jin, J., Cheng, K., Chen, M.-R., Liang, H., & Zhang, W.-G. (2025) · International Journal on Biological Sciences · doi:10.7150/ijbs.117394 · Cited by 14 · see citing works

From MASLD to HCC: What's in the middle?

Provera, A., Vecchio, C., Sheferaw, A. N., Stoppa, I., Pantham, D., Dianzani, U., & Sutti, S. (2024) · Heliyon · doi:10.1016/j.heliyon.2024.e35338 · Cited by 22 · see citing works

Gut–Liver Microbiome and Tumor Microenvironment in Metabolic Dysfunction-Associated Steatotic Liver Disease

CHIMENE-WEISS, J. I., Bromfield, B. B., Feldman, T., Gheewalla, G., Mitten, E. K., Portincasa, P., & Baffy, G. (2026) · Advances in experimental medicine and biology · doi:10.1007/978-3-032-12166-0_4

Tumor microenvironment and metabolic reprogramming in MASLD-related hepatocellular carcinoma

Zhang, V. X., Yu, T. C.-Y., Tsui, Y., & Ng, I. O. (2026) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2026.04.010 · Cited by 1 · see citing works